{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:49Z","timestamp":1791025669066,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00520-013-1878-4","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T08:11:54Z","timestamp":1372925514000},"page":"3071-3077","source":"Crossref","is-referenced-by-count":46,"title":["Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer"],"prefix":"10.1007","volume":"21","author":[{"given":"Sang-Yeon","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Seon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hwan","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Mi","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Min","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanno","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Ram","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yup","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"1878_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V86.2.685.bloodjournal862685","volume":"86","author":"R Bataille","year":"1995","unstructured":"Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86:685\u2013691","journal-title":"Blood"},{"key":"1878_CR2","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1158\/1078-0432.CCR-07-0746","volume":"13","author":"WL Bigbee","year":"2007","unstructured":"Bigbee WL, Grandis JR, Siegfried JM (2007) Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients. Clin Cancer Res 13:3107\u20133108","journal-title":"Clin Cancer Res"},{"key":"1878_CR3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2362.2000.00751.x","volume":"30","author":"M Bossola","year":"2000","unstructured":"Bossola M, Muscaritoli M, Bellantone R, Pacelli F, Cascino A, Sgadari A, Battaglia F, Piccioni E, Scambia G, Doglietto GB, Rossi Fanelli F (2000) Serum tumour necrosis factor-alpha levels in cancer patients are discontinuous and correlate with weight loss. Eur J Clin Investig 30:1107\u20131112","journal-title":"Eur J Clin Investig"},{"issue":"6","key":"1878_CR4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hed.21557","volume":"33","author":"KP Chang","year":"2011","unstructured":"Chang KP, Chang YT, Wu CC, Liu YL, Chen MC, Tsang NM, Hsu CL, Chang YS, Yu JS (2011) Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival. Head Neck 33(6):886\u2013897","journal-title":"Head Neck"},{"issue":"9","key":"1878_CR5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/ijc.27892","volume":"132","author":"CH Chang","year":"2013","unstructured":"Chang CH, Hsiao CF, Yeh YM, Chang GC, Tsai YH, Chen YM, Huang MS, Chen HL, Li YJ, Yang PC, Chen CJ, Hsiung CA, Su WC (2013) Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. Int J Cancer 132(9):1977\u20131985","journal-title":"Int J Cancer"},{"key":"1878_CR6","first-page":"152","volume":"6","author":"YS Choi","year":"2003","unstructured":"Choi YS, Lee J, Park JN, Lee MA, Yeom CH, Jang SK (2003) Reliability and validity of the evaluation of Korean cancer pain assessment tool (K-CPAT). Korean J Hosp Palliat Care 6:152\u2013163","journal-title":"Korean J Hosp Palliat Care"},{"key":"1878_CR7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/cncr.21485","volume":"104","author":"M Nisio Di","year":"2005","unstructured":"Di Nisio M, Niers TM, Reitsma PH, Buller HR (2005) Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration. Cancer 104:2275\u20132281","journal-title":"Cancer"},{"key":"1878_CR8","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1182\/blood.V84.8.2472.2472","volume":"84","author":"D Emilie","year":"1994","unstructured":"Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay JY, Gabarre J, Gaillard JP, Brochier J, Raphael M (1994) Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 84:2472\u20132479","journal-title":"Blood"},{"issue":"12","key":"1878_CR9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00384-012-1493-8","volume":"27","author":"P Ferroni","year":"2012","unstructured":"Ferroni P, Riondino S, Portarena I, Formica V, La Farina F, Martini F, Massimiani G, Palmirotta R, Guadagni F, Roselli M (2012) Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer. Int J Colorectal Dis 27(12):1561\u20131567","journal-title":"Int J Colorectal Dis"},{"key":"1878_CR10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2354.2007.00874.x","volume":"17","author":"M Grim-Stieger","year":"2008","unstructured":"Grim-Stieger M, Keilani M, Mader RM, Marosi C, Schmidinger M, Zielinski CC, Fialka-Moser V, Crevenna R (2008) Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate\u2014preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy. Eur J Cancer Care (Engl) 17:454\u2013462","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1878_CR11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","volume":"38","author":"Y Guo","year":"2012","unstructured":"Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38:904\u2013910","journal-title":"Cancer Treat Rev"},{"key":"1878_CR12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V97.6.1590","volume":"97","author":"E Haddad","year":"2001","unstructured":"Haddad E, Paczesny S, Leblond V, Seigneurin JM, Stern M, Achkar A, Bauwens M, Delwail V, Debray D, Duvoux C, Hubert P, Hurault de Ligny B, Wijdenes J, Durandy A, Fischer A (2001) Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1\u20132 clinical trial. Blood 97:1590\u20131597","journal-title":"Blood"},{"key":"1878_CR13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00432-012-1176-4","volume":"138","author":"EA Hamed","year":"2012","unstructured":"Hamed EA, Zakhary MM, Maximous DW (2012) Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol 138:999\u20131009","journal-title":"J Cancer Res Clin Oncol"},{"key":"1878_CR14","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","volume":"110","author":"DS Hong","year":"2007","unstructured":"Hong DS, Angelo LS, Kurzrock R (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110:1911\u20131928","journal-title":"Cancer"},{"key":"1878_CR15","first-page":"37","volume":"3","author":"J Illman","year":"2005","unstructured":"Illman J, Corringham R, Robinson D Jr, Davis HM, Rossi JF, Cella D, Trikha M (2005) Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 3:37\u201350","journal-title":"J Support Oncol"},{"key":"1878_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oraloncology.2011.02.006","volume":"47","author":"A Korostoff","year":"2011","unstructured":"Korostoff A, Reder L, Masood R, Sinha UK (2011) The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol 47:282\u2013287","journal-title":"Oral Oncol"},{"key":"1878_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0269216311406991","volume":"26","author":"SM Kwak","year":"2012","unstructured":"Kwak SM, Choi YS, Yoon HM, Kim DG, Song SH, Lee YJ, Yeom CH, Koh SJ, Park J, Lee MA, Suh SY (2012) The relationship between interleukin-6, tumor necrosis factor-alpha, and fatigue in terminally ill cancer patients. Palliat Med 26:275\u2013282","journal-title":"Palliat Med"},{"key":"1878_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jama.290.1.98","volume":"290","author":"EB Lamont","year":"2003","unstructured":"Lamont EB, Christakis NA (2003) Complexities in prognostication in advanced cancer: \u201cto help them live their lives the way they want to\u201d. JAMA 290:98\u2013104","journal-title":"JAMA"},{"key":"1878_CR19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0959-8049(00)00291-4","volume":"36","author":"J Llobera","year":"2000","unstructured":"Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, Pons O, Catalan G, Avella A (2000) Terminal cancer. duration and prediction of survival time. Eur J Cancer 36:2036\u20132043","journal-title":"Eur J Cancer"},{"key":"1878_CR20","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","volume":"18","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J (2012) Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res 18:2290\u20132300","journal-title":"Clin Cancer Res"},{"key":"1878_CR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1200\/JCO.2000.18.3.699","volume":"18","author":"CL Loprinzi","year":"2000","unstructured":"Loprinzi CL, Johnson ME, Steer G (2000) Doc, how much time do I have? J Clin Oncol 18:699\u2013701","journal-title":"J Clin Oncol"},{"key":"1878_CR22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1442-2050.2011.01242.x","volume":"25","author":"M Lukaszewicz-Zajac","year":"2012","unstructured":"Lukaszewicz-Zajac M, Mroczko B, Kozlowski M, Niklinski J, Laudanski J, Szmitkowski M (2012) Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. Dis Esophagus 25:242\u2013249","journal-title":"Dis Esophagus"},{"key":"1878_CR23","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","volume":"23","author":"M Maltoni","year":"2005","unstructured":"Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations\u2014a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240\u20136248","journal-title":"J Clin Oncol"},{"key":"1878_CR24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1634\/theoncologist.2011-0397","volume":"17","author":"M Maltoni","year":"2012","unstructured":"Maltoni M, Scarpi E, Pittureri C, Martini F, Montanari L, Amaducci E, Derni S, Fabbri L, Rosati M, Amadori D, Nanni O (2012) Prospective comparison of prognostic scores in palliative care cancer populations. Oncologist 17:446\u2013454","journal-title":"Oncologist"},{"key":"1878_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1998.0398","volume":"11","author":"F Martin","year":"1999","unstructured":"Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito MJ, Oramas J (1999) Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11:80\u201386","journal-title":"Cytokine"},{"key":"1878_CR26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2000.02093.x","volume":"109","author":"P Moreau","year":"2000","unstructured":"Moreau P, Harousseau JL, Wijdenes J, Morineau N, Milpied N, Bataille R (2000) A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma. Br J Haematol 109:661\u2013664","journal-title":"Br J Haematol"},{"key":"1878_CR27","first-page":"1091","volume":"21","author":"AG Moses","year":"2009","unstructured":"Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21:1091\u20131095","journal-title":"Oncol Rep"},{"key":"1878_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0885-3924(02)00596-1","volume":"25","author":"T Okuyama","year":"2003","unstructured":"Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y (2003) Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manag 25:106\u2013117","journal-title":"J Pain Symptom Manag"},{"key":"1878_CR29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/14712598.2010.503773","volume":"10","author":"F Penna","year":"2010","unstructured":"Penna F, Minero VG, Costamagna D, Bonelli G, Baccino FM, Costelli P (2010) Anti-cytokine strategies for the treatment of cancer-related anorexia and cachexia. Expert Opin Biol Ther 10:1241\u20131250","journal-title":"Expert Opin Biol Ther"},{"key":"1878_CR30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(05)73853-8","volume":"356","author":"A Pirisi","year":"2000","unstructured":"Pirisi A (2000) US researchers find key link in muscle-wasting syndrome. Lancet 356:1249","journal-title":"Lancet"},{"key":"1878_CR31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1470-2045(08)70197-9","volume":"9","author":"CC Reyes-Gibby","year":"2008","unstructured":"Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S (2008) Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 9:777\u2013785","journal-title":"Lancet Oncol"},{"key":"1878_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","volume":"31","author":"C Scheede-Bergdahl","year":"2012","unstructured":"Scheede-Bergdahl C, Watt HL, Trutschnigg B, Kilgour RD, Haggarty A, Lucar E, Vigano A (2012) Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr 31:85\u201388","journal-title":"Clin Nutr"},{"key":"1878_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrc2507","volume":"8","author":"B Seruga","year":"2008","unstructured":"Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887\u2013899","journal-title":"Nat Rev Cancer"},{"key":"1878_CR34","unstructured":"Statistics Korea (2012) Causes of death statistics in 2011"},{"key":"1878_CR35","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s12032-010-9645-6","volume":"28","author":"C Su","year":"2011","unstructured":"Su C, Zhou C, Zhou S, Xu J (2011) Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Med Oncol 28:1453\u20131457","journal-title":"Med Oncol"},{"key":"1878_CR36","first-page":"171","volume":"10","author":"SY Suh","year":"2007","unstructured":"Suh SY (2007) Survival prediction of terminally ill cancer patients. Korean J Hosp Palliat Care 10:171\u2013177","journal-title":"Korean J Hosp Palliat Care"},{"key":"1878_CR37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejca.2007.01.031","volume":"43","author":"SY Suh","year":"2007","unstructured":"Suh SY, Ahn HY (2007) Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer 43:1051\u20131059","journal-title":"Eur J Cancer"},{"key":"1878_CR38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00520-006-0208-5","volume":"15","author":"SY Suh","year":"2007","unstructured":"Suh SY, Ahn HY (2007) A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Support Care Cancer 15:613\u2013620","journal-title":"Support Care Cancer"},{"key":"1878_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00520-009-0639-x","volume":"18","author":"SY Suh","year":"2010","unstructured":"Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, Park SA, Kim S, Seo JY, Kim SH, Kim D, Choi SE, Ahn HY (2010) Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 18:151\u2013157","journal-title":"Support Care Cancer"},{"key":"1878_CR40","first-page":"560","volume":"40","author":"Y Toiyama","year":"2012","unstructured":"Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M (2012) Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int J Oncol 40:560\u2013566","journal-title":"Int J Oncol"},{"key":"1878_CR41","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1158\/1078-0432.CCR-09-2152","volume":"15","author":"S Trompet","year":"2009","unstructured":"Trompet S, de Craen AJ, Mooijaart S, Stott DJ, Ford I, Sattar N, Jukema W, Westendorp RG (2009) High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clin Cancer Res 15:7744\u20137748","journal-title":"Clin Cancer Res"},{"key":"1878_CR42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.145.1.397","volume":"145","author":"K Utsumi","year":"1990","unstructured":"Utsumi K, Takai Y, Tada T, Ohzeki S, Fujiwara H, Hamaoka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145:397\u2013403","journal-title":"J Immunol"},{"key":"1878_CR43","volume-title":"The 10 leading causes of death by broad income group","author":"World Health Organization","year":"2011","unstructured":"World Health Organization (2011) The 10 leading causes of death by broad income group. WHO, Geneva"},{"key":"1878_CR44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpainsymman.2004.04.013","volume":"29","author":"YH Yun","year":"2005","unstructured":"Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Mendoza TR, Cleeland CS (2005) Validation study of the Korean version of the brief fatigue inventory. J Pain Symptom Manag 29:165\u2013172","journal-title":"J Pain Symptom Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1878-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1878-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1878-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T21:08:38Z","timestamp":1715634518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1878-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1878-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}